Projects We Fund
Pioneering science and innovation in cancer research is in our DNA
We’ve seen first hand how even a small breakthrough can make a significant difference in the survival chances of children and young people. That’s why we pour our fundraising into research, working closely with scientists and medical experts to improve diagnosis and find better, kinder treatments. Over the last 35 years, we’ve funded over 300 cancer research projects for children and young people.
Developing immunotherapy for childhood sarcomas.
Research Developing immunotherapy for childhood sarcomas. Some childhood cancers don’t respond well to chemotherapy, but there is hope in the…
Read more Developing immunotherapy for childhood sarcomas.
Childhood cancer immunotherapy using blood cells from umbilical cord blood.
Research Childhood cancer immunotherapy using blood cells from umbilical cord blood. Immunotherapy is an important new approach in the treatment…
Read more Childhood cancer immunotherapy using blood cells from umbilical cord blood.
Focusing on immunotherapy to target cancer cells without damaging healthy cells
Research Focusing on immunotherapy to target cancer cells without damaging healthy cells Developing new treatments for childhood cancers can be…
Read more Focusing on immunotherapy to target cancer cells without damaging healthy cells
Causes Cancers Blood
Finding out why some children get rare cancers of the blood. At the moment, we don’t know the cause of…
Read more Causes Cancers Blood
Unravelling the world-wide survival disparities in children, teenagers and young adults with leukaemia and lymphoma
Research Unravelling the world-wide survival disparities in children, teenagers and young adults with leukaemia and lymphoma This project is studying…
Read more Unravelling the world-wide survival disparities in children, teenagers and young adults with leukaemia and lymphoma
Focusing on immunotherapy to target cancer cells without damaging healthy cells
Research Focusing on immunotherapy to target cancer cells without damaging healthy cells Developing new treatments for childhood cancers can be…
Read more Focusing on immunotherapy to target cancer cells without damaging healthy cells
Childhood cancer immunotherapy using blood cells from umbilical cord blood
Research Childhood cancer immunotherapy using blood cells from umbilical cord blood Immunotherapy is an important new approach in the treatment of…
Read more Childhood cancer immunotherapy using blood cells from umbilical cord blood
Immunotherapy for infant and childhood MLL-rearranged acute lymphoblastic leukaemia
Research Immunotherapy for infant and childhood MLL-rearranged acute lymphoblastic leukaemia Young children with mixed lineage leukaemia rearranged infant acute lymphoblastic…
Read more Immunotherapy for infant and childhood MLL-rearranged acute lymphoblastic leukaemia
Immunotherapy for relapsed paediatric acute lymphoblastic leukaemia
Research Immunotherapy for relapsed paediatric acute lymphoblastic leukaemia Stem cell transplant is used as a treatment of last resort in young…
Read more Immunotherapy for relapsed paediatric acute lymphoblastic leukaemiaWhy do we need funding for our projects?
Cancer is the leading cause of death in children aged 1–14 years in the UK. Survivors often face a lifetime of serious health issues due to the intensive treatments used to combat the disease. Unlike adult cancers, childhood cancers are biologically different and require dedicated research to improve outcomes.
Children with Cancer UK is a proud member of the Association of Medical Research Charities (AMRC) and fully supports the AMRC’s position on the use of animals in research. You can read our full Animal Research Position Statement to learn more.
